NCT00115622

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 14 Days in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 304 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as "hay fever", it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.

Conditions

• Hayfever
• Rhinitis, Allergic, Seasonal
• Seasonal Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	fluticasone furoate

Timeline

• Start date: 2004-12-01
• Primary completion: 2005-01-01
• Completion: 2005-01-01
• First posted: 2005-06-24
• Last updated: 2016-09-01

Locations

4 sites across 1 country: United States